Beyond the labThe Geoffrey Beene Cancer Research Center annual retreats continue to promote a vibrant research community at Memorial Sloan-Kettering Cancer Center by enhancing the collaboration among different departments across the institution.
Welcome MessageCharles Sawyers, Chair of the Human Oncology and Pathogenesis Program, opens the annual retreat at Skytop Lodge, in Skytop, Pennsylvania.
Session I: Genomic Approaches to Cancer Gene DiscoveryMichael Berger, Department of Pathology, presents “Targeted DNA Sequencing in Clinical Tumor Specimens for Discovery and Diagnostics.”
Session I: Genomic Approaches to Cancer Gene DiscoveryCraig Thompson, President of Memorial Sloan-Kettering Cancer Center, fields questions from audience members.
Retreat AttendeesRetreat attendees included senior scientists, physicians, junior faculty members, postdoctoral researchers, and graduate students from different departments across the institution.
Audience MembersLisa DeAngelis, Chair of the Department of Neurology, during a session presentation
Audience MembersJames Hsieh, Human Oncology and Pathogenesis Program, comments during a session presentation.
Poster Session IPostdoctoral researchers discuss their work with fellow trainees.
OutdoorsAttendees enjoy the trails around the Skytop Lodge during a break from presentations.
OutdoorsPostdoctoral researchers speak with William Sellers, Vice President and Global Head of Oncology at the Novartis Institute of Biomedical Research, during a break from the presentations.
Geoffrey Beene Cancer Research Center Retreat’s Guest SpeakerScott Lowe, Chair of the Geoffrey Beene Cancer Research Center, introduces guest speaker William Sellers and thanks the Geoffrey Beene Foundation for its continued support of the Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering.
Geoffrey Beene Cancer Research Center Retreat’s Guest SpeakerWilliam Sellers, Vice President and Global Head of Oncology at the Novartis Institute of Biomedical Research, discusses the opportunities and challenges presented by studying the genetic basis of therapy.
Poster Session II(From left) Ingo Mellinghoff, of the Human Oncology and Pathogenesis Program, and fellows Owen Clark and Daniel Rohle during the poster session.
Session III: Debate on Drug Development in Academia and IndustryRonald DeMatteo, of the Department of Surgery, poses a question to the debaters.
Session III: Debate on Drug Development in Academia and IndustryCharles Sawyers moderates the debate between William Sellers and Neal Rosen.
Session III: Debate on Drug Development in Academia and IndustryMilan Chheda, of the Department of Neurology, engages in the conversation during the debate.
Session IV: Cancer Imaging and TherapyMichael Evans of Jason Lewis’s laboratory discusses measuring cancer biology in vivo with Zr-89 radiopharmaceuticals.
Session V: Targeting the Ras PathwayMaggie Callahan of Jedd Wolchok’s laboratory presents on the rational development of multimodal therapy on melanoma.
Session V: Targeting the Ras PathwayJames Fagin, of the Human Oncology and Pathogenesis Program, presents on thyroid oncogenesis and MAPK dependence.
Closing MessageJoan Massagué, Chair of the Cancer Biology and Genetics Program, closes the event by recognizing the efforts of all the scientists at the retreat and thanking the Geoffrey Beene Cancer Research Center for sponsoring the fifth annual retreat.